SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1361George, what time was that trade? Island book shows a last match at 49.90 at 19tom pope-7/10/2001
1360There was a single trade of over 106 k shares in the afttermarket. It was done aknahow-7/10/2001
1359Mark, Trading bgen at these levels. Looks like we will hold $50. Timing looks rimichael97123-7/9/2001
1358George, it doesn't do much good to sling mud around. Biogen has problems: pHarold Engstrom-7/8/2001
1357Is Wong right, or Wrong? For a long time I doubted BGEN had any role in the p.raknahow-7/8/2001
1356Correct previous post: Journal name is NEUROLOGY.Cacaito-6/29/2001
1355Rebif Vs Rebif in New England Journalof Med: 4 year follow up study of Rebif 44Cacaito-6/28/2001
1354Gw, the controversy seems to be the "clearance at any point" results pCacaito-6/26/2001
1353Gw, June 22, no surprise data, all the IV treatments numbers available to anallCacaito-6/26/2001
1352Serono's Rebif 44mcg 3x a week vs Bgen's Avonex 30mcg once a week, compCacaito-6/26/2001
1351Salomon's Elise Wang: Bgen an outperform, PW has a Hold.Cacaito-6/26/2001
1350If the FDA spends tax dollars saying beware resistance to antibiotics why turn daknahow-6/26/2001
1349Gw, do not compare Amevive proven results at all levels with Natrecor very bordeCacaito-6/25/2001
1348Completed phase II and "Elan and Biogen met with the FDA last week to discuCacaito-6/25/2001
1347You posted: "Do remember that Amevive is better than 'currently&#aknahow-6/25/2001
1346Good thoughts Mike. Watch for the market to take off at some point with biotechsMark Bong-6/25/2001
1345George, we certainly agree that nothing is a slam dunk with the FDA. I was usingMark Bong-6/25/2001
1344Mark, 50-65, sometimes high 40's to low 70's has been the story for overmichael97123-6/25/2001
1343You posted: "This seems like a slam-dunk for approval from the FDA." aknahow-6/25/2001
1342"3. Antegren is phase III for both MS and Crohn's indications" AnHarold Engstrom-6/25/2001
1341Mike, I have heard a few fund managers state that BGEN is a wonderful trading stMark Bong-6/25/2001
1340Curren PE 34, Growth of Avonex has slow down but it is currently $1 billion in Cacaito-6/25/2001
1339Mark & Thread, Any ideas on where the stock will base? as opposed to the drumichael97123-6/25/2001
1338Not going to be a good day for BGEN holders if it does not rebound from the openaknahow-6/25/2001
1337To:Cacaito who wrote (15441) From: Bluegreen Sunday, Jun 24, 2001 11:49 PM ResBluegreen-6/25/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News